Risk factors predicting refractoriness in epileptic children with partial seizures

Related Experiment Video

Updated: Jul 13, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Sakir Altunbasak1, Ozlem Herguner, H Refik Burgut

  • 1Department of Pediatric Neurology, Cukurova University, Medical Faculty, Adana, Turkey. sakira@cu.edu.tr

Journal of Child Neurology
|July 11, 2007
PubMed

Insights

Identifying risk factors for intractable childhood epilepsy is crucial. Factors like neurological abnormalities and seizure type predict therapy resistance, guiding early intervention and surgical referral for better outcomes.

Area of Science:

  • Neurology
  • Pediatric Epilepsy

Background:

  • Childhood epilepsy affects numerous children globally.
  • Intractability to therapy poses significant challenges in pediatric epilepsy management.

Purpose of the Study:

  • To identify risk factors associated with therapy intractability in childhood epilepsy.
  • To guide early referral for specialized treatment, including epilepsy surgery.

Main Methods:

  • Retrospective study comparing 50 children with intractable epilepsy to a control group.
  • Statistical analysis including chi-squared tests, odds ratio calculation, and logistic multiple regression.

Main Results:

  • Univariate analysis identified mental retardation, neurological/neuroradiological abnormalities, perinatal anoxia, neonatal convulsions, status epilepticus, and symptomatic etiology as significant risk factors.
  • Multivariate analysis confirmed age at seizure onset, status epilepticus, mixed seizure types, and frequent seizures as independent risk factors.
  • The intractable epilepsy group used a significantly higher number of antiepileptic drugs.

Conclusions:

  • Specific clinical and etiological factors predict intractable epilepsy in children.
  • Early identification of these risk factors is essential for timely referral to specialized epilepsy centers, potentially for surgical evaluation.

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...